Guides › TB-500 Dosage & Reconstitution Guide

TB-500 Dosage & Reconstitution Guide

Complete reference for TB-500 dosing, reconstitution math, and protocol planning. Covers vial sizes, concentrations, loading vs maintenance phases, and how it compares to BPC-157.

What TB-500 Is

TB-500 is a synthetic analogue of Thymosin Beta-4, a naturally occurring protein involved in tissue repair, cell migration, and inflammation regulation. It is widely studied in research contexts for its role in recovery processes.

Unlike short-acting peptides that are dosed multiple times daily, TB-500 has a significantly longer half-life — measured in days — making weekly or biweekly protocols the standard approach in most research frameworks.

Typical Vial Sizes and Concentrations

Vial SizeWater AddedConcentration2 mg dose5 mg dose
5 mg1 mL5 mg/mL0.40 mL1.00 mL
5 mg2 mL2.5 mg/mL0.80 mL2.00 mL
10 mg2 mL5 mg/mL0.40 mL1.00 mL
10 mg4 mL2.5 mg/mL0.80 mL2.00 mL

Higher water volumes produce lower concentrations and larger injection volumes per dose.

Reconstitution Workflow

  1. Confirm vial amount — Check the label for total mg content
  2. Choose a water volume — Common choices are 1–4 mL depending on target concentration
  3. Add bacteriostatic water — Inject slowly against the vial wall, do not spray onto powder
  4. Swirl gently — Do not shake; allow the powder to dissolve completely
  5. Calculate your draw — Use ClearDosage to convert your dose to mL or syringe units
  6. Label and refrigerate — Mark date, concentration, and vial ID

Dosing Math Example

Setup: 10 mg vial, 2 mL water → concentration = 5 mg/mL = 5,000 mcg/mL

Target dose: 2 mg (2,000 mcg)

Target dose: 5 mg (5,000 mcg)

Enter your vial size, water volume, and dose into the ClearDosage calculator to generate draw amounts for any setup.

Common Planning Approaches

Research protocols for TB-500 vary widely, but several patterns appear frequently in the literature:

Loading phase: Higher doses used for an initial period (often 4–6 weeks) followed by a maintenance phase with lower doses.

Maintenance phase: Reduced dose frequency after the loading period — commonly biweekly or monthly.

Stack context: TB-500 is frequently paired with BPC-157 in research frameworks due to their complementary tissue repair mechanisms. Both are typically dosed separately.

Individual protocols depend on research context, body weight, and goals. Consult a qualified clinician before any personal use.

TB-500 vs BPC-157: Key Differences

TB-500BPC-157
OriginThymosin Beta-4 analogueGastric peptide sequence
Half-lifeDaysMinutes to hours
Typical frequencyWeekly / biweeklyOnce or twice daily
Common routeSubcutaneousSubcutaneous or oral
Primary research focusSystemic repair, inflammationLocal tissue repair, GI

Because TB-500 works systemically and BPC-157 tends to be more site-specific in research models, they are often used together in recovery-focused protocols. ClearDosage lets you save separate configurations for each and view their half-life curves simultaneously in the Half-Life Visualizer.

Common Mistakes

Confusing mg and mcg — TB-500 doses are specified in mg (not mcg), which is larger than most peptide doses. Double-check the unit before calculating.

Using too much water — Concentrations below 1 mg/mL result in large injection volumes per dose. A 2 mL injection is generally the practical upper limit for subcutaneous delivery.

Skipping the loading phase calculation — Loading doses are typically higher than maintenance. Save separate configurations in ClearDosage for each phase to avoid drawing the wrong amount.

Not tracking vial date — TB-500 vials reconstituted in bacteriostatic water have a finite refrigerated shelf life. Use the Vial Tracker in ClearDosage to log reconstitution dates and receive expiry alerts.

Use the ClearDosage calculator to set up your TB-500 concentration once, save it, and refer back to it without recalculating from scratch each time.

Calculate Your Dose →
For research and informational purposes only. This is not medical advice. Not FDA-approved for human use. Consult a qualified healthcare provider before using any peptide.